Sandalan, Manuel G.
HRN: 10-64-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/07/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/07/2025
05/14/2025
IV
500mg
Q8h
T/c Intraabdominal Infection, ETBD
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes